These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Functions of the surfactant proteins: a perspective. Hawgood S; Poulain FR Pediatr Pulmonol; 1995 Feb; 19(2):99-104. PubMed ID: 7659473 [No Abstract] [Full Text] [Related]
6. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Benne CA; Benaissa-Trouw B; van Strijp JA; Kraaijeveld CA; van Iwaarden JF Eur J Immunol; 1997 Apr; 27(4):886-90. PubMed ID: 9130640 [TBL] [Abstract][Full Text] [Related]
7. Potential role of surfactant proteins A and D in innate lung defense against pathogens. van Golde LM Biol Neonate; 1995; 67 Suppl 1():2-17. PubMed ID: 7647156 [TBL] [Abstract][Full Text] [Related]
8. The structure and function of surfactant protein-A. McCormack F Chest; 1997 Jun; 111(6 Suppl):114S-119S. PubMed ID: 9184556 [No Abstract] [Full Text] [Related]
9. Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity. Reid KB Immunobiology; 1998 Aug; 199(2):200-7. PubMed ID: 9777406 [TBL] [Abstract][Full Text] [Related]
11. Lung surfactant proteins A and D in innate immune defense. Vaandrager AB; van Golde LM Biol Neonate; 2000 May; 77 Suppl 1():9-13. PubMed ID: 10828580 [TBL] [Abstract][Full Text] [Related]
12. Degradation of human and rat surfactant apoprotein by neutrophil elastase and cathepsin G. Lewis RW; Harwood JL; Tetley TD; Harris E; Richards RJ Biochem Soc Trans; 1993 May; 21(2):206S. PubMed ID: 8359457 [No Abstract] [Full Text] [Related]
13. Neutrophil proteinases and rhDNase therapy in cystic fibrosis. Vogelmeier C; Döring G Eur Respir J; 1996 Nov; 9(11):2193-5. PubMed ID: 8947058 [No Abstract] [Full Text] [Related]
14. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747 [TBL] [Abstract][Full Text] [Related]
15. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary surfactant proteins A and D are involved in the early response to intratracheally aerosolized lipopolysaccharide. Van Rozendaal BA; Van de Lest CH; Van Eijk M; Van Helden HP; Haagsman HP Biochem Soc Trans; 1997 Nov; 25(4):S656. PubMed ID: 9450084 [No Abstract] [Full Text] [Related]
18. Effects of pulmonary surfactant and surfactant protein A on phagocytosis of fractionated alveolar macrophages: relationship to starvation. Sakai K; Kweon MN; Kohri T; Kishino Y Cell Mol Biol; 1992 Apr; 38(2):123-30. PubMed ID: 1571941 [TBL] [Abstract][Full Text] [Related]
19. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Hickman-Davis JM; Lindsey JR; Zhu S; Matalon S Am J Physiol; 1998 Feb; 274(2):L270-7. PubMed ID: 9486213 [TBL] [Abstract][Full Text] [Related]
20. Cathepsin-G interferes with clearance of Pseudomonas aeruginosa from mouse lungs. Sedor J; Hogue L; Akers K; Boslaugh S; Schreiber J; Ferkol T Pediatr Res; 2007 Jan; 61(1):26-31. PubMed ID: 17211136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]